Nestle, Bullish On Palforzia, To Buy Remainder Of Aimmune

Firm Will Create Food Allergy Subsidiary

 
• By Joseph Haas
  
Peanut allergy concept
Nestle wants to fully own the only approved peanut allergy therapy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business